ClinicalTrials.gg
Sign In

HIV Infections clinical trials

The registry lists 4,735 studies for HIV Infections across more than 10 countries. 245 are recruiting or about to start. 3,700 of them are mainly about HIV Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 7 narrower conditions too, such as Acquired Immunodeficiency Syndrome: 6,825 studies, 542 open.

ClinicalTrials.gov finds 10,180 studies for HIV Infections. How that becomes 4,735 here

This page counts the studies the registry files under HIV Infections, and those it files under no condition that list HIV Infectionsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 10,180Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −2,067Filed under a narrower condition, counted on its own pageAcquired Immunodeficiency Syndrome 1,895 · HIV Seropositivity 126 · AIDS Dementia Complex 16 · AIDS-related Kaposi sarcoma 10 · HIV-Associated Lipodystrophy Syndrome 9 · AIDS-Related Complex 7 · 1 more
  3. −18List HIV Infections as a condition, but the registry did not file them under itMost often written as “Chronic HIV Infection” (3), “Acute HIV Infection” (2), and “HIV Infection Primary” (2). The registry filed them under other conditions only, most often Hepatitis C, Chronic (2) and Hepatitis (2).
  4. −3,360Match it another way107 name it in the title, 7 in a keyword, and 3,246 by a synonym or other text the search reads.
  5. 4,735The count on this page56 of them list HIV Infections in their own words; the registry filed them under no condition.

Get an email when these change. Save the HIV Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
3,742
Status unknown
290
Terminated
231
Recruiting
159
Withdrawn
115
Active, not recruiting
93

Phase

Phase 1
1,004
Phase 2
934
Phase 3
608
Phase 4
414
Early Phase 1
10

Where

United States
2,802
Puerto Rico
331
South Africa
305
France
278
Spain
261
Canada
236

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (1,034) · ViiV Healthcare (154) · Gilead Sciences (81) · University of North Carolina, Chapel Hill (79) · Bristol-Myers Squibb (75) · ANRS, Emerging Infectious Diseases (73) · Glaxo Wellcome (72) · Merck Sharp & Dohme LLC (70)

What is being tested here

Drugs under test in HIV Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dolutegravir72353
Lamivudine551132
Emtricitabine41864
Cabotegravir41336
Tenofovir alafenamide4922
VH4524184307
Darunavir21438
Doravirine207
Dezecapavir206
Bictegravir204

Drug classes tested here Integrase inhibitors 16 open · Reverse transcriptase inhibitors 12 open · Tyrosine kinase inhibitors (TKIs) 2 open · Opioids 1 open · Antimitotic agents 1 open

Coming up

26phase 3 studies under way
102studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 159 HIV Infections studies recruiting now, 104 (65%) set no upper age limit and 42 (26%) stop at 75 or younger. 31 (19%) take children under 18. 14 (9%) are for women only and 14 (9%) for men only; 60 (38%) take healthy volunteers.

Recruiting studies that take each age, of 159
AgeWomenMen
106 (4%)6 (4%)
18127 (80%)131 (82%)
30125 (79%)125 (79%)
40125 (79%)123 (77%)
50127 (80%)127 (80%)
65113 (71%)114 (72%)
75110 (69%)109 (69%)
85106 (67%)105 (66%)

Across all 4,735 studies, recruiting or not: 36% stop at 75 or younger and 33% at 65; 27% take children; 8% are for women only and 6% for men only; 26% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long HIV Infections studies take

Of 165 phase 1 interventional studies under HIV Infections, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 119 mo7–33 · 165 studies5 mo2–18 · 74 studies27 mo18–46 · 91 studies
Phase 1/247 mo22–73 · 42 studies—55 mo29–73 · 35 studies
Phase 231 mo17–58 · 99 studies19 mo12–31 · 34 studies37 mo24–74 · 65 studies
Phase 2/341 mo33–60 · 11 studies——
Phase 327 mo20–46 · 101 studies22 mo18–30 · 57 studies43 mo26–63 · 44 studies
Phase 435 mo23–44 · 91 studies—36 mo25–45 · 78 studies
Interventional, no phase28 mo16–45 · 402 studies—28 mo16–45 · 393 studies
Observational38 mo16–69 · 201 studies—37 mo16–69 · 187 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting2

Results posted5

Stopped1

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 4,735. Browse all 4,735 → or search them.